These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 30807558)

  • 1. NALIRIFOX for metastatic pancreatic adenocarcinoma: hope or hype?
    Nevala-Plagemann C; Garrido-Laguna I
    Nat Rev Clin Oncol; 2024 Aug; 21(8):567-568. PubMed ID: 38664532
    [No Abstract]   [Full Text] [Related]  

  • 2. Current management and future directions in metastatic pancreatic adenocarcinoma.
    Varghese AM; Lowery MA; Yu KH; O'Reilly EM
    Cancer; 2016 Dec; 122(24):3765-3775. PubMed ID: 27649047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease.
    Gromisch C; Qadan M; Machado MA; Liu K; Colson Y; Grinstaff MW
    Cancer Res; 2020 Aug; 80(16):3179-3192. PubMed ID: 32220831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic adenocarcinoma: Beyond first line, where are we?
    Cherri S; Noventa S; Zaniboni A
    World J Gastroenterol; 2021 May; 27(17):1847-1863. PubMed ID: 34007126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Real time
    Kim DW; Beato F; Kim Y; Tassielli AF; Dai R; Denbo JW; Hodul PJ; Malafa MP; Fleming JB
    Oncotarget; 2024 Jul; 15():441. PubMed ID: 38953899
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of patients with metastatic pancreatic cancer].
    Wirth T; Nitschmann S
    Inn Med (Heidelb); 2024 Aug; 65(8):853-854. PubMed ID: 39023783
    [No Abstract]   [Full Text] [Related]  

  • 7. Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates.
    King DA; Smith AR; Pineda G; Nakano M; Michelini F; Goedegebuure SP; Thyparambil S; Liao WL; McCormick A; Ju J; Cioffi M; Zhang X; Hundal J; Griffith M; Grandori C; Pollastro M; Rosati R; Margossian A; Chatterjee P; Ainge T; Flory M; Ocampo P; Chen LM; Poultsides GA; Baron AD; Chang DT; Herman JM; Gillanders WE; Park H; Hoos WA; Nichols M; Fisher GA; Kuo CJ
    JCO Precis Oncol; 2023 Apr; 7():e2100489. PubMed ID: 37079860
    [No Abstract]   [Full Text] [Related]  

  • 8. Small steps can lead to substantial breakthroughs: moving the therapeutic needle forward in pancreatic cancer.
    Pathak P; Weekes C; Wo JY
    Lancet Oncol; 2024 Jul; 25(7):824-825. PubMed ID: 38834088
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous metastatic pancreatic adenocarcinoma.
    Nasser S; Husseini A; Pasula S; Sandhu A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34728510
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug Development Against Metastatic Cancers.
    Wang C; Huang S
    Yale J Biol Med; 2017 Mar; 90(1):119-123. PubMed ID: 28356899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating landmark trial-based evidence to the front lines of care for pancreatic cancer: the evolving trial-based and guideline-supported role for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
    Lima CMSR
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):3-5. PubMed ID: 30807559
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic Approaches for Metastatic Pancreatic Adenocarcinoma.
    Rubinson DA; Wolpin BM
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):761-76. PubMed ID: 26226909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising new therapies in advanced pancreatic adenocarcinomas.
    Kundranda M; Kachaamy T
    Future Oncol; 2014 Dec; 10(16):2629-41. PubMed ID: 25531049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic advances in metastatic pancreatic adenocarcinoma and related cancers: focus on evidence-based and sequenced approaches to survival extension in metastatic pancreatic adenocarcinoma.
    Bekaii-Saab T; Yu K; Lima CMSR; Wolin EM
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):1-16. PubMed ID: 30807558
    [No Abstract]   [Full Text] [Related]  

  • 15. A treatment landscape in evolution: new strategies, guidelines, and therapeutic advances for metastatic pancreatic adenocarcinoma.
    Bekaii-Saab T
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):5-7. PubMed ID: 30807560
    [No Abstract]   [Full Text] [Related]  

  • 16. Identifying ideal candidates for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
    Yu K
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):9-10. PubMed ID: 30807562
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.